O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait
Condition: Diabetes Mellitus, Type 2 Intervention: Drug: Semaglutide Sponsor: Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Endocrinology | Kuwait Health | Middle East Health | Research | Saudi Arabia Health | Study | UAE Health